Company
Last deal
$39.5M
Amount
Venture - Series Unknown
Stage
24.11.2023
Date
7
all rounds
$128.M
Total amount
General
About Company
Octave Bioscience is a molecular diagnostics company that focuses on neurodegenerative diseases and conditions.
Industry
Sector :
Subsector :
Keywords :
founded date
01.01.2013
Number of employees
Company Type
For Profit
Last funding type
Venture - Series Unknown
IPO status
Private
Contacts
location
Phone number
Website URL